Tissium
TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Paris, Francetissium.com ↗
Total raised
€100M
€100,000,000
Funding rounds
2
Investors
6
distinct backers
Active since
2021-08
latest 2023-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood39
base rate 53% for Series D+
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Exit likelihood17
base rate 12% (2+ rounds)
- ▲ €100M+ raised
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-23 | Series D+ | €50M | Cathay Health,Credit Mutuel Innovation,Fonds Stratégique des Transitions,Merieux Developpement,Sofinnova Partners | View deal → |
| 2021-08-31 | Series C | €50M | Cathay Capital,Sofinnova Partners | View deal → |
Investors
6Related news
- French biotech Tissium stitches up €50 milliontech.eu · 2021-08
- siliconcanals.com
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software